|
According to
a new study published in the Aug. 17 issue of the New England
Journal of Medicine, a tough-to-treat staphylococcus bug is
now the leading cause of skin and soft-tissue infections in the
U.S. Methicillin-resistant Staphylococcus Aureus (MRSA) is
resistant to the antibiotic methicillin and other common antibiotics
such as oxacillin, penicillin and amoxicillin.
Staph infections,
including MRSA, occur most frequently among persons in hospitals
and healthcare facilities, including nursing homes and dialysis
centers, who have weakened immune systems. Symptoms can range from
benign skin infections to bloodstream infections to potentially
fatal heart valve infections.
Funded by the
U.S. Centers for Disease Control & Prevention (CDC), the study involved
cultured skin or soft-tissue infections from 422 patients at emergency
rooms in eleven cities across the U.S. Of the 422 cases reviewed
for the study, researchers reported that 59 percent had MRSA.
The occurrence of MRSA ranged from 15 to 74 percent, depending on
the city.
While the MRSA
germ thrives in healthcare settings, outbreaks have occurred with
frequency among prisoners, children and athletes.
MRSA infection
prevention practices include avoiding sharing towels, razors or
other common hygiene items, and by practicing proper hand hygiene
regimes, including frequent washing with soap and water.
For the abstract
of the study by Moran et al from the New England Journal of Medicine,
please go to:
http://content.nejm.org/cgi/content/abstract/355/7/666
To find out
more about MRSA from the CDC, please go to:
http://www.cdc.gov/ncidod/dhqp/ar_mrsa_ca.html
|